Facebook Twitter LinkedIn Google Plus RSS

Rutgers, NJDOH chosen to participate in prostate cancer study

By ,

The New Jersey Department of Health and Rutgers Cancer Institute have been chosen to participate in a $26.5 million, statewide cancer surveillance and population-based epidemiological cancer research study of prostate cancer among African-American men.

The study is being led by the Keck School of Medicine of the University of Southern California, and supported by the National Cancer Institute, the National Institute on Minority Health and Health Disparities and the Prostate Cancer Foundation.

New Jersey State Cancer Registry director Dr. Antoinette Stroup of Rutgers Cancer Institute and Dr. Karen Pawlish from the New Jersey Department of Health will act as the collaborators on the Research on Prostate Cancer in Men of African Ancestry study.

The goal of the study is to determine social and biological factors that contribute to prostate cancer in African-American men in the state. According to Rutgers Cancer Institute, the incidence of prostate cancer among African-American men in New Jersey is 50 percent higher than Caucasian men. African-American men in the state also die from prostate cancer at a rate more than two and half times higher than that for Caucasian men.

Also Popular on NJBIZ

Vince Calio

Vince Calio

Vince Calio covers health care and manufacturing for NJBIZ. You can contact him at vcalio@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy